Ausdal Financial Partners’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,007
Closed -$32.8K 520
2024
Q2
$32.8K Buy
+10,007
New +$32.8K ﹤0.01% 488